BOSTON & GENEVA--(BUSINESS WIRE)--PHT Corporation cemented its reputation as the dominant player and constant innovator in the Patient Reported Outcomes (PRO) and Electronic Patient Reported Outcomes (ePRO) industry with the announcement of its 500th clinical research trial.
